Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | CA9 | Q16790 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29956607 | 1.00 | CA12 (0.56) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL29955511 | 0.86 | CA12 (0.55) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL1163297 | 0.86 | CA12 (0.55) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL3363446 | 0.83 | CA12 (0.55) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL18199882 | 0.83 | CA12 (0.55) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL30425563 | 0.79 | ACHE (0.60) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL27757975 | 0.79 | ACHE (0.60) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL11971153 | 0.75 | CA9 (0.56) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL11971156 | 0.75 | CA9 (0.56) | CA12CA9ALDH1A1MCL1CYP2A6 | |
| SCHEMBL5144216 | 0.74 | CYP2A6 (0.65) | CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117645708-A | Photo-thermal repair polyurea with adjustable performance based on multiple dynamic bonds and preparation method thereof | 浙江万亿星新材料科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-115557878-A | Indocyanine derivatives, and preparation and application thereof | 广西大学 | 2023-01-03 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| US-12570654-B2 | Nanoluc suicide substrates | PROMEGA CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| CN-119701896-A | Method for extracting coumarin from lavender | 李雪 | 2025-03-28 | — | — | CN | disclosed |
| CN-117645708-A | Photo-thermal repair polyurea with adjustable performance based on multiple dynamic bonds and preparation method thereof | 浙江万亿星新材料科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117645708-A | Photo-thermal repair polyurea with adjustable performance based on multiple dynamic bonds and preparation method thereof | 浙江万亿星新材料科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| US-20230382908-A1 | NANOLUC SUICIDE SUBSTRATES | PROMEGA CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11655247-B2 | Nanoluc suicide substrates | PROMEGA CORPORATION (US) | 2023-05-23 | — | — | US | disclosed |
| CN-115557878-A | Indocyanine derivatives, and preparation and application thereof | 广西大学 | 2023-01-03 | — | — | CN | disclosed |
| EP-3788048-A1 | COELENTERAZINE COMPOUNDS AS NANOLUC SUICIDE SUBSTRATES | Promega Corporation (US) | 2021-03-10 | — | — | EP | disclosed |
| US-7026491-B2 | Coumarin derivatives useful as TNFα inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-04-11 | — | — | US | disclosed |
| US-20060020138-A1 | Coumarin derivatives useful as TNFalpha inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-01-26 | — | — | US | disclosed |
| WO-2005054179-A2 | HYDROXAMIC ACID ESTERS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2005-06-16 | — | — | WO | disclosed |
| EP-1531820-A1 | ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Memory Pharmaceuticals Corporation (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20050014705-A1 | Coumarin derivatives useful as tnf alpha inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-01-20 | — | — | US | disclosed |
| US-20040229868-A1 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | MEMORY PHARMACEUTICALS CORP. | 2004-11-18 | — | — | US | disclosed |
| WO-2004019943-A1 | ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | MEMORY PHARMACEUTICALS CORPORATION (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2002008217-A2 | COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382908-A1 | NANOLUC SUICIDE SUBSTRATES | XIAP, NLN, BAD | CA12 4710/4885CA9 4720/4885ALDH1A1 2032/4885 |
| US-20040229868-A1 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | CHRNA1, CHRNA4, CHRNA3 | CA12 2418/4885CA9 2549/4885ALDH1A1 370/4885 |
| US-20050014705-A1 | Coumarin derivatives useful as tnf alpha inhibitors | TNF, NFKBIA, TNFRSF1A | CA12 3775/4885CA9 3821/4885ALDH1A1 1457/4885 |
| US-11655247-B2 | Nanoluc suicide substrates | XIAP, NLN, BAD | CA12 4710/4885CA9 4720/4885ALDH1A1 2032/4885 |
| US-12570654-B2 | Nanoluc suicide substrates | NR3C1, LUC7L2, L3MBTL1 | CA12 3938/4885CA9 3334/4885ALDH1A1 1718/4885 |
| US-20060020138-A1 | Coumarin derivatives useful as TNFalpha inhibitors | TNF, NFKBIA, TNFRSF1A | CA12 3397/4885CA9 3930/4885ALDH1A1 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.